This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Rhodes Technologies, Other. Active years: 2012-2015.
Company Filing History:
1 out of 47 
1 out of 834,453 Years Active: 2012-2015
Title: The Innovative Contributions of Brenda E. Richardson
Introduction
Brenda E. Richardson is a notable inventor based in Manchester, MA (US). She has made significant contributions to the field of medical science, particularly in the development of methods for eliminating chemical substances from the blood. With a total of 2 patents to her name, her work has the potential to impact various therapeutic approaches.
Latest Patents
Brenda's latest patents focus on innovative methods and dosage regimens for reducing the concentration of chemical substances in blood plasma. One of her patents describes a method that involves titrating an initial peak concentration of a chemical or drug substance in the blood for a predefined dosing period. It also includes titrating the lowest concentration level of the substance immediately before the end of the dosing period. This method ensures that the lowest concentration level for subsequent dosing periods is decreased by no more than five percent of the previous period's lowest concentration level, extending the overall treatment duration to seventy days or more. Another patent similarly targets receptors in the central or peripheral nervous system, employing a comparable titration method to achieve effective results.
Career Highlights
Throughout her career, Brenda has worked with various organizations, including Rhodes Technologies. Her experience in these companies has allowed her to refine her skills and contribute to significant advancements in her field.
Collaborations
Brenda has collaborated with notable professionals such as Kenneth C. Slater and Scott M. Connors. These partnerships have likely enriched her work and expanded the impact of her inventions.
Conclusion
Brenda E. Richardson's innovative methods for eliminating chemical substances from the blood demonstrate her commitment to advancing medical science. Her contributions are poised to make a lasting impact on therapeutic practices.